Navigation Links
Kensey Nash Announces Mediated Settlement With St. Jude Medical in Angio-Seal License Disputes and 5 Year Extension and Expansion of Collagen Supply Agreement
Date:3/16/2012

EXTON, Pa., March 16, 2012 /PRNewswire/ -- Kensey Nash Corporation (NASDAQ: KNSY) today announced that the Company has entered into a settlement agreement with St. Jude Medical which resolves all disputes between the two companies relating to the Angio-Seal vascular closure device licenses, as well as other related claims. As part of the settlement agreement, the companies also agreed to extend their collagen supply agreement through 2017 and expand the minimums to be provided over the contract term to five million units.

Under the terms of the agreement, Kensey Nash will receive $39 million from St. Jude, payable in 12 equal quarterly payments beginning March 31, 2012, in lieu of all future royalties for the Angio-Seal and all other related claims. The Company expects to recognize the $39 million as royalty revenue on a straight line basis beginning January 2012 through April 2014, which is the expiration of the last to expire of patents exclusively licensed by Kensey Nash to St. Jude under the settlement agreement and acknowledged by both parties to cover the Angio-Seal device. Additionally, Kensey Nash will continue to be the exclusive outside supplier of collagen for the Angio-Seal device through 2017. The approximate value of the minimum orders under the collagen supply agreement over the five year extension is $31 million.

"We are pleased the mediation process led to a fair and swift resolution for both parties, and we are excited that our long-term relationship with St. Jude will continue through at least 2017. This settlement eliminates the uncertainty that had existed with our royalty income and our role as a long term supplier of collagen," commented Joe Kaufmann, President and CEO.

Updated Fiscal 2012 Guidance.  As a result of the settlement, the Company has now updated its fiscal 2012 guidance as follows:

(in millions except
'/>"/>

SOURCE Kensey Nash Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Kensey Nash Announces IDE Submission for Cartilage Repair Device
2. Kensey Nash Announces Presentations on its Cartilage Repair Device at the International Cartilage Repair Society Meeting
3. Kensey Nash Corporation Announces Its First Quarter Fiscal Year 2010 Earnings Release Date and Teleconference
4. Kensey Nash Reports Second Quarter Fiscal Year 2010 Financial Results
5. Kensey Nash Receives FDA 510(k) Clearance for Porcine Dermis Biologic Product
6. Kensey Nash Announces $30 Million Share Buyback
7. Kensey Nash to Present at the Canaccord Adams Musculoskeletal Conference
8. Kensey Nash To Participate in the Sidoti Fourteenth Annual New York Emerging Growth Institutional Investor Forum
9. Kensey Nash Corporation Announces the Addition of Donald Morel, Jr., Ph.D. to Its Board of Directors
10. Kensey Nash to Present at the Ninth Annual JMP Securities Research Conference
11. KENSEY NASH Receives FDA 510(k) Clearance for ECM Product, Meso BioMatrix Surgical Mesh
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... July 31, 2015 The Physician-Patient Alliance ... on July 28, 2015, "Surviving Your Hospital Stay: ... for Patient Safety." A sentence was ... read: "PPAHS is a member of ... Opioids. For more information on the National Coalition to ...
(Date:7/31/2015)...  Xcelience, a contract development and manufacturing organization ... structured cash investment in Powdersize, a ... and powder size classification within the pharmaceutical industry.  ... simultaneously adding a complete set of particle size ... "As we continue to build our ...
(Date:7/31/2015)... PORTLAND, Ore., July 31, 2015  Semler Scientific, Inc. ... and testing services to healthcare insurers and physician groups, ... June 30, 2015. "In the second ... over year revenue growth of 54%, quarter over quarter ... of the installed base of FloChec® units of 18%," ...
Breaking Medicine Technology:Xcelience Makes Structured Cash Investment in Powdersize 2Xcelience Makes Structured Cash Investment in Powdersize 3Semler Reports Second Quarter 2015 Financial Results 2Semler Reports Second Quarter 2015 Financial Results 3Semler Reports Second Quarter 2015 Financial Results 4Semler Reports Second Quarter 2015 Financial Results 5Semler Reports Second Quarter 2015 Financial Results 6
... SAN DIEGO, Jan. 19, 2012 Sequenom, Inc. (NASDAQ: SQNM ... to market and other conditions, shares of its common stock in ... whether or when the offering may be completed, or as to ... & Company, Inc. is acting as sole book-running manager for the ...
... 19, 2012 Medicare officials should swiftly authorize a Special ... Medicare Part D prescription drug plan if the patient believes ... "preferred network" plan with inadequate pharmacy access, the National ... the start of the 2012 plan year on January 1, ...
Cached Medicine Technology:Sequenom Announces Proposed Public Offering of Common Stock 2Pharmacists Ask Medicare to Help Seniors Complaining About Inadequate Pharmacy Access in Medicare Prescription Drug Plans 2Pharmacists Ask Medicare to Help Seniors Complaining About Inadequate Pharmacy Access in Medicare Prescription Drug Plans 3
(Date:8/3/2015)... ... 03, 2015 , ... Recent reports by the American Medical Association show that ... their lives. Often time, low back and sciatic pain can happen as a result ... clinically with powerful pain medication or spinal surgery. Dynamic Health Care in Louisville, ...
(Date:8/2/2015)... ... August 03, 2015 , ... A new Phase I ... childhood cancers. The study is led by Kenneth G. Lucas, M.D. , chief ... Louisville in collaboration with colleagues at Kosair Children’s Hospital and in the ...
(Date:8/2/2015)... Orion, Clarkston, Metamora Michigan (PRWEB) , ... ... ... Pelvic Organ Prolapse (POP) results when the supportive muscles and connective tissues ... damaged. Causes of this weakness and damage include straining, heavy lifting, obesity, ...
(Date:8/1/2015)... In (PRWEB) , ... August 02, 2015 , ... ... month which will help the continuity of care for patients at this natural health ... of the unknown," Clinic Director Mary Heal said. "Heather's role is vital to our ...
(Date:8/1/2015)... ... 2015 , ... Western University of Health Sciences’ newest class ... growing percentage of U.S. physicians, and reflects the diversity of the communities where ... message delivered by John W. Becher, DO, president of the American Osteopathic Association, ...
Breaking Medicine News(10 mins):Health News:Dynamic Health Care in Louisville, KY, Offers a New and Cutting-Edge Therapy for Low Back & Leg Pain Sufferers 2Health News:UofL Physicians Conducting Vaccine Trial for Children with Relapsed Tumors at Kosair Children’s Hospital 2Health News:Minimally Invasive and Robotic Treatment for Pelvic Organ Prolapse Now Available from the Specialists at Women’s Excellence in Bladder Control 2Health News:New Patient Advocate Enhances Natural Health Care 2Health News:COMP-Northwest Welcomes Class of 2019 2Health News:COMP-Northwest Welcomes Class of 2019 3Health News:COMP-Northwest Welcomes Class of 2019 4Health News:COMP-Northwest Welcomes Class of 2019 5
... WARWICK , R. I., Jan. 13 Plan, an ... $100,000 in emergency funds to help Haiti ... death toll from the 7.23 magnitude quake is not yet known, ... When the earthquake struck, buildings and public infrastructure, including at least ...
... Enbrel in head-to-head comparison and requires fewer injections, researchers ... estimated 7.5 million Americans suffering from psoriasis often have ... effective. , Now, a new drug called ustekinumab (Stelara) ... etanercept (Enbrel), according to the results of a head-to-head ...
... ... Works Association’s (AWWA) 2010 Annual Conference & Exposition (ACE10), June 20-24, in Chicago, Illinois ... Denver, CO ... Works Association’s (AWWA) 2010 Annual Conference & Exposition (ACE10), June 20-24, in Chicago, Illinois., ...
... ... equipment world by storm, and experts think the technology could have far reaching implications ... ... billionaire Sir Richard Brandstone of Virgin Atlantis to launch a Jet Powered Mobility Scooter ...
... SAN FRANCISCO , Jan. 13 The ... opportunity for Brown & Toland, San Francisco,s largest ... our new partnership with California Pacific Medical Center, we are ... record (EMR), to a greater number of community physicians," said ...
... procedure unwarranted for chronic tendinopathy, researchers say , ... for overuse injury of the Achilles tendon doesn,t appear ... in the Netherlands concluded that platelet-rich plasma (PRP) injections ... improving a patient,s ability to be active. , The ...
Cached Medicine News:Health News:Plan Disaster Teams on the Ground in Haiti 2Health News:Newer Drug More Effective in Psoriasis Treatment 2Health News:Newer Drug More Effective in Psoriasis Treatment 3Health News:AWWA Announces ACE10 Registration is Now Open, 2Health News:Jet Powered Mobility Scooter Revolutionizes Mobility Transportation 2Health News:Jet Powered Mobility Scooter Revolutionizes Mobility Transportation 3Health News:Brown & Toland Board Releases Update 2Health News:Brown & Toland Board Releases Update 3